High somatic mutation and neoantigen burden are correlated with decreased progression-free survival in multiple myeloma.
Blood Cancer J
; 7(9): e612, 2017 09 22.
Article
in En
| MEDLINE
| ID: mdl-28937974
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Mutation, Missense
/
Multiple Myeloma
/
Antigens, Neoplasm
Type of study:
Clinical_trials
/
Guideline
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Blood Cancer J
Year:
2017
Document type:
Article
Affiliation country:
Country of publication: